Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamic Equivalence of Albuterol Sulfate to PROAIR® HFA in Stable, Mild Asthma
NCT03528577Phase 3Completed
- Sponsor
- Sun Pharma
- Start
- Sep 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of salbutamol in asthma, sponsored by Sun Pharma. Started Sep 2018; status: completed.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03528577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03528577.